Henshaw Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,177
Closed -$225K 330
2020
Q2
$225K Sell
1,177
-1,777
-60% -$311K 0.02% 272
2020
Q1
$458K Buy
2,954
+193
+7% +$22.5K 0.05% 146
2019
Q4
$231K Buy
+2,761
New +$210K 0.02% 243

Other funds holding TDOC

Henshaw Capital's TDOC Position: Q3 2020 in Review

Henshaw Capital sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 1,177 shares — an estimated $225K sold.

Henshaw Capital first reported a position in TDOC in Q4 2019 and held it in 3 quarters. The position peaked at $458K in Q1 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • Henshaw Capital reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
  • Henshaw Capital sold 1,177 Teladoc Health shares in Q3 2020, an estimated $225K.
  • Henshaw Capital first reported a position in Teladoc Health in Q4 2019 and held it in 3 quarters.
  • Henshaw Capital's Teladoc Health position peaked at $458K in Q1 2020.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Henshaw Capital's 13F filing for Q3 2020, filed 28 May 2026.